D. Huet

Significance of circulating T-cell clones in Sezary syndrome.

M. Bagot, P. Musette, N. Ortonne, 2006, Blood.

Killer cell Ig-like receptors CD158a and CD158b display a coactivatory function, involving the c-Jun NH2-terminal protein kinase signaling pathway, when expressed on malignant CD4+ T cells from a patient with Sezary syndrome.

M. Bagot, N. Ortonne, A. Bensussan, 2007, Blood.

SC5 mAb Represents a Unique Tool for the Detection of Extracellular Vimentin as a Specific Marker of Sézary Cells1

P. Ferrara, M. Bagot, J. Capdevielle, 2006, The Journal of Immunology.

Circulating natural killer lymphocytes are potential cytotoxic effectors against autologous malignant cells in sezary syndrome patients.

M. Bagot, N. Ortonne, A. Bensussan, 2005, The Journal of investigative dermatology.